Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pajkrt

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Intensive Care Medicine|January 1, 1997
Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host?D Pajkrt, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2001
[Activated protein C, coagulation, inflammation, and treatment of severe sepsis]S J van Deventer, D Pajkrt
Current Topics in Microbiology and Immunology|January 1, 1996
The cellular response in sepsisD Pajkrt, S J van Deventer
Intensive Care Medicine|May 1, 1997
Neutrophil adhesion molecules and MOFS J van Deventer, D Pajkrt
Immunology Letters|July 27, 2001
Effect of interleukin 10 on the release of the CXC chemokines growth related oncogene GRO-alpha and epithelial cell-derived neutrophil activating peptide (ENA)-78 during human endotoxemiaD P Olszyna, D Pajkrt, S J van Deventer, et al.
Vox Sanguinis|January 25, 2005
Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical courseM Bruin, A Dassen, D Pajkrt, et al.
Gastroenterology|March 1, 1990
Glycosylation of lactase-phlorizin hydrolase in rat small intestine during developmentH A Büller, E H Rings, D Pajkrt, et al.
The Journal of Infectious Diseases|February 11, 2000
Interleukin 10 inhibits the release of CC chemokines during human endotoxemiaD P Olszyna, D Pajkrt, F N Lauw, et al.
AIDS Care|April 1, 2021
Health-related quality of life of perinatally HIV-infected young people: a longitudinal studyA M Ter Haar, M Van den Hof, H J Scherpbier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Proinflammatory effects of IL-10 during human endotoxemiaF N Lauw, D Pajkrt, C E Hack, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Intensive Care Medicine|January 1, 1997
Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host?D Pajkrt, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2001
[Activated protein C, coagulation, inflammation, and treatment of severe sepsis]S J van Deventer, D Pajkrt
Current Topics in Microbiology and Immunology|January 1, 1996
The cellular response in sepsisD Pajkrt, S J van Deventer
Intensive Care Medicine|May 1, 1997
Neutrophil adhesion molecules and MOFS J van Deventer, D Pajkrt
Immunology Letters|July 27, 2001
Effect of interleukin 10 on the release of the CXC chemokines growth related oncogene GRO-alpha and epithelial cell-derived neutrophil activating peptide (ENA)-78 during human endotoxemiaD P Olszyna, D Pajkrt, S J van Deventer, et al.
Vox Sanguinis|January 25, 2005
Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical courseM Bruin, A Dassen, D Pajkrt, et al.
Gastroenterology|March 1, 1990
Glycosylation of lactase-phlorizin hydrolase in rat small intestine during developmentH A Büller, E H Rings, D Pajkrt, et al.
The Journal of Infectious Diseases|February 11, 2000
Interleukin 10 inhibits the release of CC chemokines during human endotoxemiaD P Olszyna, D Pajkrt, F N Lauw, et al.
AIDS Care|April 1, 2021
Health-related quality of life of perinatally HIV-infected young people: a longitudinal studyA M Ter Haar, M Van den Hof, H J Scherpbier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Proinflammatory effects of IL-10 during human endotoxemiaF N Lauw, D Pajkrt, C E Hack, et al.
Pageof 4